Using retinoic acid derivative molecules to antagonize the TGF-beta induced early liver fibrosis
博士 === 國立成功大學 === 基礎醫學研究所 === 96 === At present, the only curative treatment for end stage liver cirrhosis is organtransplantation. However, the availability of donor organ limits the application of this treatment. The current anti-fibrotic effect of antioxidants is disappointing in vivo due probabl...
Main Authors: | Kun-Lin Yang, 楊昆霖 |
---|---|
Other Authors: | Eric I. Li |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/51948157471200925280 |
Similar Items
-
Bone morphogenetic protein-2 antagonizes TGF-beta-induced renal cellular fibrosis by promoting catabolism of type I TGF-beta receptors
by: Yi-Shiuan Liu, et al.
Published: (2007) -
Study of the inhibitory effects of PPAR ligands on the TGF-beta-induced liver fibrosis.
by: Ching-Ju Cheng, et al.
Published: (2006) -
Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
by: Li-xia Tang, et al.
Published: (2012-01-01) -
Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
by: Kun-Lin Yang, et al.
Published: (2017-01-01) -
Antagonism between Retinoic Acid and Fibroblast Growth Factor Signaling during Limb Development
by: Thomas J. Cunningham, et al.
Published: (2013-05-01)